Indications and Outcomes of Hepatopancreatoduodenectomy for Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma: A Single Center Retrospective Study

胆囊癌和肝外胆管癌肝胰十二指肠切除术的适应症和预后:单中心回顾性研究

阅读:2

Abstract

INTRODUCTION: Hepatopancreatoduodenectomy (HPD) is the only definitive approach to achieve curative resection in locally advanced biliary tract cancers. The study intends to analyze outcomes of this complex surgery in a tertiary care center in Nepal. METHODS: This retrospective study included all patients who underwent HPD for locally advanced biliary tract tumors in Kathmandu Medical College Teaching Hospital from January 1, 2019 to December 31, 2023. Intra-operative findings and postoperative outcomes were analyzed. RESULTS: Over 5 years, eight patients underwent HPD. Mean age was 60 (45-69) years with a male-to-female ratio of 3:5. Locally advanced carcinoma of the gall bladder (Ca GB) comprised the majority of indications for HPD (n = 7), two of which had biliary infiltration. Others had either a conglomerated station 13 lymph node, duodenal infiltration, or both. Segment IV and V of the liver were resected in five patients, and right hemihepatectomy with non-anatomical wedge resection of segment IVb was performed in two patients with right hepatic artery involvement. One patient underwent right hemihepatectomy for Bismuth Type IIIa perihilar tumor with distal biliary infiltration and right hepatic artery involvement. R0 resection was achieved in 62.5% of the patients. All three patients with tumor infiltrating the biliary tract had R1 resection. Mean ICU and hospital stay was 2.75 ± 1.28 days and 7.62 ± 1.41 days, respectively. Clavien-Dindo Grade II or higher morbidity was observed in 5 (62.5%) patients, with one perioperative mortality (12.5%). CONCLUSION: R0 resection with acceptable morbidity can be achieved in selected cases of Ca GB with conglomerated station 13 lymph nodes; however, R0 remains challenging in cases of biliary infiltration.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。